Omni Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-06-2024
- Paid Up Capital ₹ 1.50 M
as on 17-06-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 M
as on 17-06-2024
- Revenue 16.33%
(FY 2023)
- Profit -1.89%
(FY 2023)
- Ebitda -3.33%
(FY 2023)
- Net Worth 14.89%
(FY 2023)
- Total Assets 6.51%
(FY 2023)
About Omni Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹2.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shalini Kumar, Manju Bhupendra, and Sunil Kumar serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC045562
- Company No.
045562
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Omni Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Kumar  | Additional Director | 27-Mar-2024 | Current |
| Manju Bhupendra | Director | 15-Mar-2012 | Current |
| Sunil Kumar | Director | 25-Feb-2005 | Current |
Financial Performance of Omni Lifesciences.
Omni Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.33% increase. The company also saw a slight decrease in profitability, with a 1.89% decrease in profit. The company's net worth Soared by an impressive increase of 14.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omni Lifesciences?
In 2023, Omni Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Altop Labs India Private LimitedActive 32 years 4 monthsShalini Kumar and Sunil Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 03 Mar 2006 | ₹2.00 M | Satisfied |
How Many Employees Work at Omni Lifesciences?
Omni Lifesciences has a workforce of 149 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omni Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omni Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
